BBIO Dividend History & Analysis | N/A Yield
BBIO has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Biotechnology
| SYMBOL | MARKET CAP USD | YIELD TTM | YIELD ON COST 5y |
|---|---|---|---|
| QIA | 6,758 M | 5.29% | 5.64% |
| NOV | 196,852 M | 4.64% | 5.27% |
| ABBV | 377,670 M | 3.24% | 7.01% |
| GILD | 160,883 M | 2.65% | 7.16% |
| AMGN | 178,605 M | 3.84% | 4.63% |
| SYMBOL | MARKET CAP USD | GROWTH RATE | CONSISTENCY |
|---|---|---|---|
| HLN | 40,616 M | 30.09% | 100.0% |
| NOV | 196,852 M | 25.64% | 91.9% |
| PHM | 2,016 M | 13.27% | 47.9% |
| BIM | 9,825 M | 9.76% | 96.0% |
| AMGN | 178,605 M | 7.84% | 100.0% |
BBIO Dividend FAQ
BridgeBio Pharma, Inc. (BBIO) is a commercial-stage biopharmaceutical company focused on genetic diseases and targeted oncology. Its portfolio includes Attruby for transthyretin-mediated amyloidosis (ATTR-CM) and NULIBRY for molybdenum cofactor deficiency, alongside late-stage clinical candidates for achondroplasia, LGMD2I, and Canavan disease. The company utilizes a decentralized hub-and-spoke business model, where individual subsidiaries focus on specific therapeutic programs to minimize cross-project risk while centralizing corporate resources.
What is the Dividend Yield of BBIO?
As of May 2026, BBIO's dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 69.12.
Does BBIO pay a dividend?
As of May 2026 BBIO does not pay a dividend.
How often does BBIO pay dividends?
Over the last 12 months, BBIO has issued dividend payments.
BBIO dividend forecast
Based on historical data, the forecasted dividends per share for BBIO for the next payments are between 0 (+0.0%) and 0 (+0.0%). This suggests the dividend will remain relatively stable. The expected Yield for the next 12 months is about -%.
Will BBIO pay dividends in 2026?
The next Ex-Dividend date for BridgeBio Pharma (BBIO) is currently unknown.
What is the next Ex-Dividend Date for BBIO?
The next Ex-Dividend date for BridgeBio Pharma (BBIO) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.
What is the Dividend Growth of BBIO?
BBIO's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of BBIO?
BBIO's 5-Year Yield on Cost is -%. If you bought BBIO's shares at 56.96 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.
What is the Payout Consistency of BBIO?
BBIO Payout Consistency is 0.0%. The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does BBIO have a good Dividend Yield?
BBIO's % Dividend Yield is considered as unknown.
What is the Dividend Payout Ratio of BBIO?
The Dividend Payout Ratio of BBIO is unknown.
What is the Dividend Rating of BBIO?
BBIO's Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.
Key Metric Definitions
Annual dividend per share divided by current share price.
Percentage of earnings paid as dividends. Below 60% = safe, above 100% = unsustainable.
Percentage of Free Cash Flow paid as dividends. More reliable than Payout Ratio since it measures actual cash.
Compound annual growth rate of dividends over the last 5 years.
Reliability of dividend payments over lifetime. Penalizes cuts and pauses.
Your effective yield if you bought 5 years ago. Shows dividend growth impact over time.
Consecutive years of dividend payments. 25+ years = Dividend Aristocrat.
Proprietary score (0-100) combining yield, growth, safety and consistency.
Last update: 2026-05-15 02:39 UTC